Sun Pharmaceutical Industries: Latest News and Updates, Top Stories, Videos, Photos About Sun Pharmaceutical Industries

Rs 8.5/Share Interim Dividend: Blue-Chip Pharma Stock Sets Record Date; Buy?

Blue-chip pharmaceutical company Sun Pharmaceutical Industries Ltd. has a market valuation of Rs. 3,40,025.78 Cr. at the end of Friday's trading session. The shares ended on a green note up by 0.76% at Rs 1417.20 a day after clocking a fresh ...

3 Pharma Stocks Set To Trade Ex-Dividend Next Week For Up To 600% Dividend

3 Large cap and mid cap pharmaceuticals sector stocks will trade ex-dividend next week for up to 600% dividend. These stocks are Zydus Lifesciences, Sun Pharmaceutical Industries, Alembic Pharmaceuticals. Check details below: 1. Zydus Lifesciences To Trade Ex-Dividend For 600% Dividend: ...

6 Big Dividend Announcements Made In Last 10 Days

6 Leading companies either announced dividends or fixed record date for payment of dividends in the last 10 days. These companies are KEC International, Berger Paints India Ltd, Xchanging Solutions Ltd, Tata Consultancy Services Ltd, Kirloskar Oil Engines Ltd, and Sun ...

Q4 Results: Pharma Co Declares Rs 4/Share Dividend, Net Profit At Rs 1984 Cr

Large cap pharma company, Sun Pharmaceutical Industries on Friday announced a consolidated net profit at Rs 1984.47 crore for the quarter ended March 31, 2023 against a loss of nearly 2277.25 crore reported in the same quarter last year. Board of ...

Motilal Oswal Retains Buy, Hold Call To 4 Large Cap Bluechip Stocks For Good Return

Brokerage firm Motilal Oswal has assigned neutral and buy rating to 4 leading large cap bluechip stocks for good gain. These stocks are Hindustan Unilever, Asian Paints, Sun Pharmaceutical Industries Ltd, and Hindustan Zinc. Check details below:{photo-feature}...

BNP Paribas Sees 17% Upside In This Multibagger Pharma Stock, Assigns Buy Call

Leading brokerage firm BNP Paribas has given buy rating to the pharmaceuticals sector stock Sun Pharmaceutical Industries Ltd for a target price of Rs 1074 with a potential upside of 17%. The company has a market capitalisation of Rs 2,20,925.34 crore. Check key takeaways below:{photo-feature} ...

Sun Pharma Shares Up On Patent Litigation Settlement

Shares of the Sun Pharmaceutical Industries was seen trading higher on Tuesday after the company announced that Ranbaxy Pharmaceuticals, a wholly-owned subsidiary entered into a Settlement Agreement with Actavis that dismisses the patent litigation suit relating to Actavis. Check the share ...

Sun Pharmaceutical Industries News